chrX-155506930-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_018196.4(TMLHE):c.963C>T(p.Ile321=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0002 in 1,207,353 control chromosomes in the GnomAD database, including 3 homozygotes. There are 132 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.000063 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.00021 ( 3 hom. 130 hem. )
Consequence
TMLHE
NM_018196.4 synonymous
NM_018196.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.49
Genes affected
TMLHE (HGNC:18308): (trimethyllysine hydroxylase, epsilon) This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant X-155506930-G-A is Benign according to our data. Variant chrX-155506930-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3051170.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chrX-155506930-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMLHE | NM_018196.4 | c.963C>T | p.Ile321= | synonymous_variant | 6/8 | ENST00000334398.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMLHE | ENST00000334398.8 | c.963C>T | p.Ile321= | synonymous_variant | 6/8 | 1 | NM_018196.4 | P1 | |
TMLHE | ENST00000369439.4 | c.963C>T | p.Ile321= | synonymous_variant | 6/7 | 1 | |||
TMLHE-AS1 | ENST00000452506.1 | n.67+17541G>A | intron_variant, non_coding_transcript_variant | 5 | |||||
TMLHE | ENST00000675642.1 | c.996C>T | p.Ile332= | synonymous_variant | 7/9 |
Frequencies
GnomAD3 genomes AF: 0.0000630 AC: 7AN: 111084Hom.: 0 Cov.: 22 AF XY: 0.0000598 AC XY: 2AN XY: 33452
GnomAD3 genomes
AF:
AC:
7
AN:
111084
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33452
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000470 AC: 86AN: 182885Hom.: 1 AF XY: 0.000769 AC XY: 52AN XY: 67609
GnomAD3 exomes
AF:
AC:
86
AN:
182885
Hom.:
AF XY:
AC XY:
52
AN XY:
67609
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000213 AC: 234AN: 1096216Hom.: 3 Cov.: 29 AF XY: 0.000359 AC XY: 130AN XY: 362282
GnomAD4 exome
AF:
AC:
234
AN:
1096216
Hom.:
Cov.:
29
AF XY:
AC XY:
130
AN XY:
362282
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000630 AC: 7AN: 111137Hom.: 0 Cov.: 22 AF XY: 0.0000597 AC XY: 2AN XY: 33515
GnomAD4 genome
AF:
AC:
7
AN:
111137
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33515
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TMLHE-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 04, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at